“We are thrilled with the results of this first in human clinical study, which establishes safety of the placement, usage and removal of the CBGM sensor lead. While neither the study nor ...

“We are thrilled with the results of this first in human clinical study, which establishes safety of the placement, usage and removal of the CBGM sensor lead. While neither the study nor prototype ...

The study met its primary endpoint, with no procedure or device related serious adverse events reported from implant through seven days post-removal of the CBGM sensor lead.

The short-term, prospective, single-arm in-hospital study placed the CBGM sensor intravascularly for four days via percutaneous procedure. Participants took part in several fixed meal and glucose ...

The study also confirmed the function of the CBGM sensor lead in the subclavian bein.